You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

bortezomib

Showing 51 - 75 of 559
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Contiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Recurrent Mantle Cell Lymphoma Trial in

Completed
Has Results
  • Contiguous Stage II Mantle Cell Lymphoma
  • +5 more
  • bortezomib
  • +9 more
  • Duarte, California
  • +1 more
Jan 12, 2022

Lymphoma Trial in Duarte, South Pasadena (biological, drug, other)

Active, not recruiting
  • Lymphoma
  • rituximab
  • +3 more
  • Duarte, California
  • +1 more
Feb 28, 2022

Mantle Cell Lymphoma Trial in Germany, Italy, Switzerland (Ibrutinib, bortezomib)

Terminated
  • Mantle Cell Lymphoma
  • Mainz, Germany
  • +18 more
Feb 24, 2022

Multiple Myeloma Trial in Worldwide (Melphalan flufenamide (Melflufen), Dexamethasone, Bortezomib)

Terminated
  • Multiple Myeloma
  • Melphalan flufenamide (Melflufen)
  • +3 more
  • Boston, Massachusetts
  • +15 more
Mar 4, 2022

Lung Diseases, Interstitial, Systemic Sclerosis, Scleroderma Trial in Chicago (Bortezomib, Placebo, Mycophenolate mofetil)

Completed
Has Results
  • Lung Diseases, Interstitial
  • +2 more
  • Bortezomib
  • +2 more
  • Chicago, Illinois
    Northwestern University
Aug 2, 2021

Multiple Myeloma, Renal Impairment, Tumors, Plasma Cell Trial in Greece (Isatuximab, Bortezomib, Cyclophosphamide)

Not yet recruiting
  • Multiple Myeloma
  • +7 more
  • Athens, Greece
  • +5 more
Mar 28, 2022

Lymphoblastic Leukemia Trial in Palo Alto (Dexamethasone, Mitoxantrone, PEG asparaginase)

Not yet recruiting
  • Lymphoblastic Leukemia
  • Palo Alto, California
    Stanford University
Apr 27, 2023

Multiple Myeloma Trial in United States (Elotuzumab, Pomalidomide, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Boston, Massachusetts
  • +5 more
Oct 28, 2021

Autologous Hematopoietic Stem Cell Transplant Recipient, Loss of Chromosome 17p, Plasma Cell Leukemia Trial in Duarte (drug,

Active, not recruiting
  • Autologous Hematopoietic Stem Cell Transplant Recipient
  • +4 more
  • bortezomib
  • +7 more
  • Duarte, California
    City of Hope
Mar 17, 2022

Multiple Myeloma, Refractory Trial in Greece, Israel (Selinexor, Dexamethasone, Bortezomib)

Recruiting
  • Multiple Myeloma, Refractory
  • Patra, Achaia, Greece
  • +15 more
Apr 4, 2022

Multiple Myeloma Trial in Worldwide (Eftozanermin alfa, Bortezomib, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Eftozanermin alfa
  • +2 more
  • Atlanta, Georgia
  • +18 more
Oct 12, 2022

Multiple Myeloma and Plasma Cell Tumor, Neurotoxicity Trial in Duarte (drug, genetic, other, procedure)

Completed
Has Results
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Neurotoxicity
  • bortezomib
  • +9 more
  • Duarte, California
    City of Hope Medical Center
Aug 17, 2021

Multiple Myeloma in Relapse Trial in Boston, Durham (Panobinostat, Dexamethasone, Lenalidomide)

Completed
  • Multiple Myeloma in Relapse
  • Boston, Massachusetts
  • +3 more
Sep 3, 2021

High-risk Smoldering Multiple Myeloma, Multiple Myeloma Trial in Boston (Daratumumab, Bortezomib, Lenalidomide)

Recruiting
  • High-risk Smoldering Multiple Myeloma
  • Multiple Myeloma
  • Boston, Massachusetts
  • +1 more
Oct 18, 2021

Multiple Myeloma Trial in Worldwide (Daratumumab, Bortezomib, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • Adelaide, Australia
  • +51 more
Feb 16, 2022

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • +3 more
  • Birmingham, Alabama
  • +25 more
Dec 9, 2022

Multiple Myeloma Trial in Germany (Isatuximab, Lenalidomide, Bortezomib)

Recruiting
  • Multiple Myeloma
  • Aachen, Germany
  • +29 more
Apr 4, 2023

Multiple Myeloma Trial in United States (Daratumumab, Lenalidomide, Bortezomib)

Recruiting
  • Multiple Myeloma
  • Ann Arbor, Michigan
  • +3 more
Jan 19, 2023

Multiple Myeloma Trial in Saint Louis (Isatuximab, Bortezomib, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 4, 2022

Multiple Myeloma Trial (Vorinostat, bortezomib, to vorinostat)

Completed
Has Results
  • Multiple Myeloma
  • (no location specified)
Apr 29, 2021

Multiple Myeloma, Primary Plasma Cell Leukemia, Extramedullary Multiple Myeloma Trial in Wuhan (Daratumumab, Carfilzomib,

Recruiting
  • Multiple Myeloma
  • +2 more
  • Wuhan, Hubei, China
    Institute of Hematology, Union Hospital, Tongji Medical College,
Nov 18, 2023

Multiple Myeloma Trial in Westwood (Bortezomib, Granulocyte colony-stimulating factor (G-CSF), Mozobil)

Completed
Has Results
  • Multiple Myeloma
  • Bortezomib
  • +2 more
  • Westwood, Kansas
    The University of Kansas Medical Center
May 24, 2021

Marginal Zone Lymphoma Trial in Zhengzhou (Bortezomib, Rituximab, Epirubicin)

Recruiting
  • Marginal Zone Lymphoma
  • Bortezomib
  • +4 more
  • Zhengzhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Aug 15, 2021

Multiple Myeloma, Chronic Kidney Disease Trial in United Kingdom (Bortezomib, Thalidomide, Bendamustine)

Completed
Has Results
  • Multiple Myeloma
  • Chronic Kidney Disease
  • Bortezomib
  • +3 more
  • Basingstoke, United Kingdom
  • +8 more
Jan 26, 2022

Multiple Myeloma Trial (Vorinostat, Bortezomib)

Completed
Has Results
  • Multiple Myeloma
  • (no location specified)
Apr 7, 2021